Updates

Incadea - First of three big contracts (worth Eu30m) announced

January 2014

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Incadea has announced that sales during 2013 were up 20% organically (expected c.Eu36m) with an ebitda margin in excess of 20%. The first of the three big contracts for its high margin SAAS-based dealer management software system (see November SCSW) has been signed with a major OEM and completion on the other two contracts is imminent. The three in aggregate should be worth Eu30m over a period of three years although some investment will be required in the current year. Buy. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Dialight

Andor

Incadea - 190p cash bid from Dealertrack; gain 128% (January 2015)

Incadea (September 2014)

Incadea (February 2014)

Incadea (November 2013)

incadea - 90% of full year forecast in the bag (June 2013)

incadea - Continues winning market share (March 2013)

incadea - Proportion of direct sales hits 76% (October 2012)

Incadea - Explosive growth from DMS software in emerging markets (September 2012)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X